PT-141

PT-141 (Bremelanotide) is a synthetic peptide that has been extensively studied for its activity on melanocortin receptor pathways.

PT-141 is primarily researched for its effects on melanocortin signalling and associated neurological and physiological pathways. Unlike peptides primarily studied for pigmentation, PT-141 research focuses on how melanocortin receptors influence sexual function, nervous system signalling and other physiological processes.

In Australia, bremelanotide is a Schedule 4 prescription-only substance and Peptiq Wellness supplies PT-141 strictly as a research compound for laboratory and scientific research purposes.

For laboratory research and in-vitro research purposes only. Not for human consumption, administration or therapeutic use.